Jia Guang-Sheng, Feng Guang-Long, Li Jin-Ping, Xu Hai-Long, Wang Hui, Cheng Yi-Peng, Yan Lin-Lin, Jiang Hui-Jie
Department of Radiology, Second Affiliated Hospital, Harbin Medical University, Harbin 150086, China.
Hepatobiliary Pancreat Dis Int. 2017 Jun;16(3):303-309. doi: 10.1016/s1499-3872(17)60018-3.
The various combination of multiphase enhancement multislice spiral CT (MSCT) makes the diagnosis of a small hepatocellular carcinoma (sHCC) on the background of liver cirrhosis possible. This study was to explore whether the combination of MSCT enhancement scan and alpha-fetoprotein (AFP) level could increase the diagnostic efficiency for sHCC.
This study included 35 sHCC patients and 52 cirrhotic patients without image evidence of HCC as a control group. The diagnoses were made by three radiologists employing a 5-point rating scale, with postoperative pathologic results as the gold standard. Receiver operating characteristic (ROC) curve analysis was performed to evaluate the diagnostic value of the three MSCT combination modes (arterial phase+portal-venous phase, arterial phase+delayed phase, arterial phase+portal-venous phase+delayed phase) and AFP levels for sHCC on the background of liver cirrhosis.
The area under ROC curve (AUC), sensitivity, and specificity of the combination of arterial phase+portal-venous phase+delayed phase were 0.93, 93%, and 82%, respectively. The average AUC of the arterial phase+portal-venous phase+delayed phase combination was significantly greater than that of the arterial phase+portal-venous phase (AUC=0.84, P=0.01) and arterial phase+delayed phase (AUC=0.85, P=0.03). Arterial phase+portal-venous phase had a smaller AUC (0.84) than arterial phase+delayed phase (0.85), but the difference was insignificant (P=0.15). After combining MSCT enhancement scan with AFP, the AUC, sensitivity, and specificity were 0.95, 94%, and 83%, respectively, indicating a greatly increased diagnostic efficiency for sHCC.
The combination of AFP and 3 phases MSCT enhancement scan could increase the diagnostic efficiency for sHCC on the background of liver cirrhosis. The application of ROC curve analysis has provided a new method and reference in HCC diagnosis.
多期增强多层螺旋CT(MSCT)的多种组合方式使得在肝硬化背景下诊断小肝癌(sHCC)成为可能。本研究旨在探讨MSCT增强扫描与甲胎蛋白(AFP)水平相结合是否能提高sHCC的诊断效率。
本研究纳入35例sHCC患者及52例无HCC影像学证据的肝硬化患者作为对照组。由三位放射科医生采用5分制评分量表进行诊断,以术后病理结果作为金标准。进行受试者操作特征(ROC)曲线分析,以评估三种MSCT组合模式(动脉期+门静脉期、动脉期+延迟期、动脉期+门静脉期+延迟期)及AFP水平对肝硬化背景下sHCC的诊断价值。
动脉期+门静脉期+延迟期组合的ROC曲线下面积(AUC)、敏感度及特异度分别为0.93、93%和82%。动脉期+门静脉期+延迟期组合的平均AUC显著大于动脉期+门静脉期(AUC=0.84,P=0.01)及动脉期+延迟期(AUC=0.85,P=0.03)。动脉期+门静脉期的AUC(0.84)小于动脉期+延迟期(0.85),但差异无统计学意义(P=0.15)。将MSCT增强扫描与AFP相结合后,AUC、敏感度及特异度分别为0.95、94%和83%,表明sHCC的诊断效率大幅提高。
AFP与MSCT三期增强扫描相结合可提高肝硬化背景下sHCC的诊断效率。ROC曲线分析的应用为HCC诊断提供了一种新方法和参考依据。